AuthorProfK

Association of British Neurologists goes Harrogate

If you’re a pwMS in the UK, make sure you have all questions to your neurologist answered by Tuesday since chances are, they will spend Wednesday – Friday in Harrogate meeting colleagues and friends at the annual meeting of the “ABN“. And given, you know, this is another one of those “first” F2F meetings since COVID-19 has – at least for now –...

MS controversies in India

Controversies in Neurology (CONy) launched about 15 years ago as an annual get together for neurologists to discuss topics where there is no single answer. And there are obviously many questions without a single answer in neurology just as in medicine as a whole. Over the years, CONy has become a fixture in the calendar of many of my colleagues. I co-chaired the MS section in March; here’s...

Instead of Monday Q&As – It’s MS Awareness Week!

You may be aware there is an annual World MS Day, celebrated every 30th of May since 2009, following an initiative by the MS International Federation. World MS Day 2020-22 has been themed *connections* There’s also MS Awareness *Week*, and if you live in the US that was early last month (sorry if you missed – I did), however here in the UK it’s *this week*. A number of events...

A call to arms, your upper limbs

ChariotMS is gaining traction, however not yet quite to the degree we would have liked. As you may remember, our trial milestones had to be revised, and our immediate target was to enrol 60 people with advanced MS (pwAMS) by the end of June, and we called this our “60:6 challenge”. At the time we took the decisions, it looked like a realistic plan. However, setting up trial sites for...

MS in Ukraine

I’ve been in touch with the Ukrainian Community of people with Multiple Sclerosis (UCMS). According to their own data, there are 22,000 people with MS living in Ukraine. The UCMS is an associate member of the European MS Platform (EMSP), which sounds frighteningly similar to other “associate memberships” of this large country… Kateryna from the UCMS just sent me the two...

MS Frontiers – get your abstracts in

With one year delay, this usually bi-annual meeting for researchers in the field of MS will take place 7-8 July 2022 in the popular waterfront city of Swansea, and I’m looking forward to it. “New beginnings” was our sub-heading for the meeting, but that seems to have dropped, at least temporarily, though in spirit it remains our motto: Whilst learning to live with COVID-19, the...

Swing low – The 60:6 challenge

ChariotMS is finally gaining the traction we’ve been hoping for for a long time. There were significant issues, of course, with the pandemic disruption and all, but hey we’ve been in this since at least 2016, yet only if you discard 2012-15 during which crucial work was undertaken to get to that first critical point – when suddenly, and almost miraculously, everybody agrees this...

#AttackMS

AttackMS was conceived on the 29th of Nov 2017 over a beer or two (or was it Elderflower?) at the Lago Maggiore. Prof Jeremy Hobart (Plymouth), ProfG and I sat down on the eve of the annual meeting of the European Charcot Foundation in Baveno, and I said something along the lines of: “Why don’t we treat MS with highly effective disease modifying treatment (HE-DMT) at first...

Will the NIHR give us the chance to test AI-assisted MRI in clinical practice?

I recently posted on the promises of AI-assisted MRI in routine follow-up of pwMS and mentioned that we’re applying, together with colleagues based in Nottingham and a commercial leader in the field (icometrix), for an NIHR award to see whether such an approach can indeed result in better “quality, efficiency and equity in the NHS care of multiple sclerosis” (from the title of...

Will 2022 be the year AI-assisted MRI enters the management of pwMS?

Regular MRI is a key element in the follow-up of pwMS, particularly those on disease modifying treatment (DMT). Why? Because MRI is significantly more sensitive in detecting MS disease activity than counting relapses and measuring disability using the EDSS (Kurtzke’s Expanded Disability Status Scale). I’m quite precise here referring to the EDSS since other clinical instruments may be...

Translate

Categories

Recent Posts

Recent Comments

Archives